Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk

58Citations
Citations of this article
193Readers
Mendeley users who have this article in their library.

You may have access to this PDF.

Abstract

Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.

Cite

CITATION STYLE

APA

Miele, L., Giorgio, V., Alberelli, M. A., De Candia, E., Gasbarrini, A., & Grieco, A. (2015, December 1). Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk. Current Cardiology Reports. Current Medicine Group LLC 1. https://doi.org/10.1007/s11886-015-0671-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free